493
Participants
Start Date
November 6, 2014
Primary Completion Date
January 31, 2017
Study Completion Date
December 31, 2025
Abemaciclib
Administered orally
Anastrozole
Administered orally
Letrozole
Administered orally
Placebo
Administered orally
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Taipei
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Beidou
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Zhonghe
Auckland City Hospital, Auckland
Institut Jules Bordet, Anderlecht
Medizinische Universität Wien, Vienna
Universitaetsklinikum Allgemeines Krankenhaus Wien, Vienna
Cliniques universitaires Saint-Luc, Brussels
St Vincent's Hospital, Sydney
Chris O'Brien Lifehouse, Camperdown
Sydney Adventist Hospital, Wahroonga
Iridium Kankernetwerk Wilrijk en Antwerp, Wilrijk
Hospital La Raza, Mexico City
Seoul National University Hospital, Seoul
Barwon Health - The Geelong Hospital, Geelong
Grupo Medico Camino Sc, Mexico City
Severance Hospital, Yonsei University Health System, Seoul
Ordensklinikum Linz, Linz
Mater Adult Hospital Brisbane, South Brisbane
Princess Alexandra Hospital, Woolloongabba
CHU UCL Namur/Site Sainte Elisabeth, Namur
The Queen Elizabeth Hospital, Woodville
Asan Medical Center, Seoul
Grand Hopital de Charleroi-Site Notre-Dame, Charleroi
Medizinische Universitaet Innsbruck, Innsbruck
St. John of God Murdoch Hospital, Murdoch
Samsung Medical Center, Seoul
Medizinische Universitaet Graz, Graz
AZ Delta, Roeselare
Mount Sinai Cancer Center, New York
Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia, Candiolo
National Cancer Center, Goyang-si
Alexandra Hospital, Athens
Seoul National University Bundang Hospital, Seongnam
Ospedale San Martino, Genoa
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Donostia / San Sebastian
Facharztzentrum Eppendorf, Hamburg
Centre Georges François Leclerc, Dijon
Centre Hospitalier de Saint-Brieuc - Hôpital Yves Le Foll, Saint-Brieuc
Kath. Marienkrankenhaus gGmbH, Hamburg
Inha University Hospital, Incheon
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Edirne
Lübecker Onkologische Schwerpunktpraxis, Lübeck
Azienda Ospedaliera Papa Giovanni XXIII, Bergamo
CHU de Besancon Hopital Jean Minjoz, Besançon
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lleida
Clinica Oncológica San Francisco, Torreón
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madrid
Centre Hospitalier Régional Universitaire de Brest - Hôpital Morvan, Brest
Candler Medical Oncology Practice - Statesboro, Savannah
Candler Medical Oncology Practice - Statesboro, Savannah
Polyclinique Bordeaux Nord, Bordeaux
Lakes Research, LLC, Miami Lakes
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Kuei Shan Hsiang
Holy Cross Hospital, Fort Lauderdale
Centre de Cancérologie du Grand Montpellier, Montpellier
Fundacion Rodolfo Padilla AC, León
Ospedale Sacro Cuore Don G. Calabria, Negrar Di Valpolicella
University of Tennessee Medical Center, Knoxville
Ospedale Bellaria - Azienda USL di Bologna, Bologna
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Taichung
Marien-Hospital Düsseldorf, Düsseldorf
Kyungpook National University Chilgok Hospital, Daegu
Ulsan University Hospital, Ulsan
Azienda Ospedaliero Universitaria di Ferrara, Cona
Hospital Civil Fray Antonio Alcalde, Guadalajara
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Malatya
Institut de Cancérologie de l'Ouest, Saint-Herblain
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Valencia
Rabin Medical Center, Petah Tikva
Polyclinique de Gentilly, Nancy
Mayo Clinic in Rochester, Minnesota, Rochester
Nuovo Ospedale di Prato-S.Stefano, Prato
Centro Oncologico Belenus, Cuernavaca
Helios Dr. Horst Schmidt Kliniken, Wiesbaden
Nebraska Hematology-Oncology, P.C., Lincoln
Centre Leon Berard, Lyon
Centro de Estudios Y Prevencion Del Cancer, Juchitán de Zaragoza
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Örebro
Klinikum Ludwigsburg, Ludwigsburg
Ospedale Perrino, Brindisi
Highlands Oncology Group, Springdale
Cancerología, Colinas Del Cimatario
Oncology Consultants P.A., Houston
Joe Arrington Cancer Center, Lubbock
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Gävle
Klinikum Rechts der Isar der TU München, München
CHD Vendee, La Roche-sur-Yon
Ironwood Cancer & Research Centers, Chandler
Universitätsklinikum Ulm, Ulm
Comprehensive Cancer Centers of Nevada, Las Vegas
TRIO-US (Translational Research in Oncology-US), Los Angeles
Central Coast Medical Oncology Corporation, Los Angeles
Orlando Health, Inc, Los Angeles
UCLA Hematology/Oncology - Parkside, Santa Monica
CBCC Global Research, Inc., Bakersfield
California Cancer Associates Research and Excellence, Fresno
North Valley Hematology/Oncology Medical Group, Los Angeles
Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte, Messina
"Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology MHRF", Moscow
European Medical Center, Moscow
Arkhangelsk Clinical Oncological Dispensary, Arkhangelsk
Clinic Complex, Saint Petersburg
Saint-Petersburg City Clinical Oncology Dispensary, Saint Petersburg
Rosmedtech Scientific Research Institute of Oncology, Saint Petersburg
Republic Oncology Dispensary of MoH of Republic Tatarstan, Kaznan
Kanagawa cancer center, Yokohama
Rambam Health Care Campus, Haifa
Meir Medical Center, Kfar Saba
Sheba Medical Center, Ramat Gan
Tel Aviv Sourasky Medical Center, Tel Aviv
Kaplan Medical Center, Rehovot
Soroka Medical Center, Beersheba
Hadassah Medical Center, Jerusalem
Cross Cancer Institute, Edmonton
Lakeridge Health, Oshawa
The Ottawa Hospital - General Campus, Ottawa
Princess Margaret Hospital (Ontario), Toronto
Hopital Notre Dame, Montreal
Jewish General Hospital, Montreal
Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (CIUSSS NÎM) - H -T, Montreal
Hopital du Saint-Sacrement, Québec
Policlinico Ospedale S. Andrea, Roma
Azienda Ospedaliera Santa Maria Terni, Terni
Aichi Cancer Center Hospital, Nagoya
Chiba cancer center, Chiba
National Hospital Organization Shikoku Cancer Center, Matsuyama
National Hospital Organization Hokkaido Cancer Center, Sapporo
Hyogo College of Medicine, Nishinomiya
Niigata Cancer Center Hospital, Niigata
Kindai University Hospital- Osakasayama Campus, Ōsaka-sayama
Saitama Prefectural Cancer Center, Kitaadachi-Gun
Shizuoka Cancer Center, Nakatogari
Jichi Medical University Hospital, Shimotsuke
Tokyo Met Cancer & Infectious Diseases Center Komagome Hp, Bunkyo-ku
Japanese Foundation for Cancer Research, Koto
Tokyo Medical University Hospital, Shinjuku-ku
National Hospital Organization Kyushu Cancer Center, Fukuoka
Hiroshima City Hospital, Hiroshima
Kyoto University Hospital, Kyoto
National Hospital Organization Osaka Medical Center, Osaka
Osaka International Cancer Institute, Osaka
Superare Centro de Infusion, México
Haga Ziekenhuis locatie Leyweg, The Hague
Leids Universitair Medisch Centrum, Leiden
Onkologicky Ustav sv. Alzbety, Bratislava
Vychodoslovensky Onkologicky ustav a.s., Košice
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Badajoz
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Barcelona
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Västerås
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Ankara
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bebbington
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Cambridge
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Manchester
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Sutton
Eli Lilly and Company
INDUSTRY